Filter
142
Filtered Results: 142
Text search:
trypanosoma
cruzi
Featured
Recommendations
5
New Publications
15
Language
Document type
Studies & Reports
43
Guidelines
27
Resource Platforms
19
No document type
19
Fact sheets
17
Manuals
5
Videos
4
Strategic & Response Plan
4
Infographics
2
Training Material
1
Dashboards/Maps
1
Countries / Regions
Global
22
Latin America and the Carribbean
20
Colombia
9
Argentina
5
Venezuela
5
Bolivia
4
Mexico
3
Paraguay
3
USA
2
Peru
2
Brazil
2
Chile
2
Honduras
1
Ecuador
1
El Salvador
1
Western Pacific Region
1
Western and Central Europe
1
Africa
1
North America
1
Uruguay
1
Authors & Publishers
Publication Years
Category
Countries
27
Clinical Guidelines
27
Public Health
13
Pharmacy & Technologies
7
Key Resources
3
Women & Child Health
1
Toolboxes
NTDs
101
HIV
3
Global Health Education
2
COVID-19
2
Planetary Health
2
Pharmacy
2
Rapid Response
1
Refugee
1
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cr... transmission, and infected patients under care. Evaluating the variation in historical exposure to infection is crucial for assessing progress and for understanding the priorities to achieve these milestones.
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that the...
Die Infektion wird durch nachtaktive, blutsaugende Raubwanzen übertragen. Während des Blutsaugens scheiden die infizierten Wanzen Trypanosomen aus, die Bindehaut, Schleimhäute, Abschürfungen und Hautverletzungen einschließlich der Bißwunde kon...
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Chagas disease is increasingly reported in Latin American migrants who have settled in Europe. It has rarely been reported in the UK due to lack of testing and awareness.
Chagas disease (American trypanosomia...
Principaux faits
D’après les estimations, 6 à 7 millions de personnes dans le monde sont infectées par Trypanosoma cruzi (T. Cruzi), le paras...
Болезнь Шагаса, известная также как американский трипаносомоз, — потенциально опасное для жизни заболевание, вызываемое простейшим паразитом ... cruzi.
Esta guía está enfocada en emitir recomendaciones para el diagnóstico y el tratamiento de la enfermedad de Chagas, como infección por Trypanosoma cruzi, agente protozoario de una parasitosis sis...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Meth...
La Tripanosomiasis Americana o Enfermedad de Chagas es una antropozoonosis,
es decir una enfermedad que afecta tanto al hombre como a numerosos animales
mamíferos y que es producida por un protozoario flagelado de la sangre y de los
tejidos el Trypanos... cruzi.
La enfermedad de Chagas, también conocida como tripanosomiasis americana, es causada por el parásito Trypanosoma cruzi. La forma más común de contraer la infección es a través del contacto con...
A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Chagas disease (CD), caused by the parasite Trypanosoma ..., affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address the many outstanding research questions. This systematic review aims to describe the characteristics and treatment practices of clinical studies in CD and assess the breadth and availability of research data for the potential establishment of a data-sharing platform.
Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in his honor, just over a century ago. He described the clinical aspects of the disease, characterized by its etiological agent (Trypanosoma ...) and identified its insect vector. Initially, CD occurred only in Latin America and was considered a silent and poorly visible disease. More recently, CD became a neglected worldwide disease with a high morbimortality rate and substantial social impact, emerging as a significant public health threat. In this context, it is crucial to better understand better the epidemiological scenarios of CD and its transmission dynamics, involving people infected and at risk of infection, diversity of the parasite, vector species, and T. cruzi reservoirs. Although efforts have been made by endemic and non-endemic countries to control, treat, and interrupt disease transmission, the cure or complete eradication of CD are still topics of great concern and require global attention. Considering the current scenario of CD, also affecting non-endemic places such as Canada, USA, Europe, Australia, and Japan, in this review we aim to describe the spread of CD cases worldwide since its discovery until it has become a global public health concern.
In areas of Mexico, Central America, and South America, where the Trypanosoma cruzi parasite is present in triatomine bugs, improved housing and spraying insecticide inside housing to eliminate the ...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disea...
A century after its discovery, Chagas' disease still represents a major public health challenge in Latin America. Moreover, because of growing population movements, an increasing number of cases of imported Chagas' disease have now been detected in non-endemic areas, such as North America and some E...
Website last accessed on 12.03.2023
Hemos considerado relevante la elaboración de audios, para diversificar los formatos a través de los cuales llegar a las personas en general, y a los equipos de salud en particular. Cuidamos que estos sean representativos de las experiencias de las personas q...
Video about Animated life cycle of T. cruzi in the human host.
Enfermedad de Chagas e inmunosupresión. Decálogo para la prevención, el diagnóstico y el tratamiento
Según las estimaciones, en las Américas hay entre 6 y 8 millones de personas con infección por T. cruzi, con aproximadamente 30 000 casos nuevos por año por transmisión vectorial, y 8000 casos nuevos anuales por transmisión congénita. Es deci...
La transmisión de T. cruzi de un donante con la enfermedad de Chagas a un receptor de trasplante es poco frecuente y es resultado de la aplicación de un tratamiento quirúrgido. En este documento se proponen diez pautas para manejar y prevenir la ...
